Pfizer22062007Chart png
Summary: approval was welcome news for Pfizer which on Wednesday had the FDA delay approval of an HIV drug and cancelled development of a lung cancer drug In a study of 750 patients 30 had a pain reduction using the drug s highest dosage 600 mg 27 on the middle dose 450 mg 24 on the lowest dose 300 mg vs 15 on placebo Pfizer shares are flat YTD vs a 4 3 gain in
Image Dimensions: 360 x 226
Image originally found here.
